• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服抗凝药物过量及中毒的药代动力学方面(作者译)

[Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].

作者信息

Jähnchen E, Meinertz T

出版信息

Arzneimittelforschung. 1977;27(96):1849-56.

PMID:303522
Abstract

Three aspects of treatment with oral anticoagulant drugs are discussed: 1. Drug interactions which can lead to changes in the elimination or distribution of oral anticoagulant drugs with special emphasis on the time course of the augmentation of the anticoagulant effect. 2. Pharmacokinetic factors responsible for inter- and intrasubject differences in the response to oral anticoagulant drugs. 3. Treatment of overdosage and intoxication with oral anticoagulant drugs. Besides symptomatic treatment with vitamin K and prothrombin complex concentrate the interruption of the enterohepatic recycling by cholestyramine is demonstrated as a useful method for enhancing the elimination of phenprocoumon and warfarin from the body.

摘要

本文讨论了口服抗凝药物治疗的三个方面

  1. 药物相互作用,这可能导致口服抗凝药物的消除或分布发生变化,特别强调抗凝作用增强的时间过程。2. 导致个体间和个体内对口服抗凝药物反应差异的药代动力学因素。3. 口服抗凝药物过量和中毒的治疗。除了使用维生素K和凝血酶原复合物浓缩物进行对症治疗外,消胆胺中断肠肝循环被证明是一种增强苯丙香豆素和华法林从体内消除的有用方法。

相似文献

1
[Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].口服抗凝药物过量及中毒的药代动力学方面(作者译)
Arzneimittelforschung. 1977;27(96):1849-56.
2
Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon.
Semin Thromb Hemost. 1999;25(1):5-11. doi: 10.1055/s-2007-996417.
3
Vitamin K and the oral anticoagulant drugs.
Annu Rev Med. 1976;27:245-61. doi: 10.1146/annurev.me.27.020176.001333.
4
The pharmacology of oral anticoagulants: implications for therapy.口服抗凝剂的药理学:对治疗的启示。
J Heart Valve Dis. 1993 Jan;2(1):53-62.
5
Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.口服抗凝治疗早期和稳定期国际标准化比值、维生素K依赖凝血因子水平与体内凝血酶原激活之间的关系
Haematologica. 2002 Oct;87(10):1074-80.
6
Management of anticoagulant poisoning--author's response.抗凝剂中毒的处理——作者回应
Vet Hum Toxicol. 2001 Jun;43(3):181.
7
[Pharmacology of oral anticoagulants].[口服抗凝剂的药理学]
Z Gesamte Inn Med. 1979 Jan 1;34(1):8-17.
8
Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine.华法林治疗患者中与腹泻相关的抗凝过度:考来烯胺的治疗作用
Vet Hum Toxicol. 2000 Dec;42(6):351-3.
9
Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial.凝血酶原复合物浓缩剂个体化给药方案在口服抗凝治疗逆转中比标准治疗更有效:一项开放、前瞻性随机对照试验。
Thromb Res. 2006;118(3):313-20. doi: 10.1016/j.thromres.2005.08.005. Epub 2005 Sep 21.
10
[Factors influencing activity of oral anticoagulants. Interactions with drugs and food].[影响口服抗凝剂活性的因素。与药物和食物的相互作用]
Pol Merkur Lekarski. 2008 May;24(143):458-62.

引用本文的文献

1
[Successful therapy of phenprocoumon poisoning with plasmapheresis].[血浆置换成功治疗苯丙香豆素中毒]
Med Klin (Munich). 1998 Mar 15;93(3):174-6. doi: 10.1007/BF03044835.
2
Factors responsible for interindividual differences in the dose requirement of phenprocoumon.
Eur J Clin Pharmacol. 1987;33(1):49-54. doi: 10.1007/BF00610379.